HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Reversible posterior leukoencephalopathy syndrome associated to bevacizumab].

AuthorsEsther M Ortiz-Lopez, José Antonio Gonzalez-Nieto, Iñigo Rojas-Marcos, Alberto Blanco-Ollero
JournalRevista de neurologia (Rev Neurol) Vol. 51 Issue 2 Pg. 117-8 (Jul 16 2010) ISSN: 1576-6578 [Electronic] Spain
Vernacular TitleLeucoencefalopatía posterior reversible asociada a bevacizumab.
PMID20602317 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
Topics
  • Aged
  • Angiogenesis Inhibitors (adverse effects, therapeutic use)
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Colonic Neoplasms (pathology)
  • Humans
  • Lung Neoplasms (drug therapy, secondary)
  • Magnetic Resonance Imaging
  • Male
  • Posterior Leukoencephalopathy Syndrome (chemically induced, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: